Hasegawa J, Mitsuhata H, Matsumoto S, Enzan K
Department of Anesthesiology, Hiraka General Hospital, Yokote.
Masui. 1992 Mar;41(3):356-62.
Effect of diltiazem on cardiovascular response to laryngoscopy and tracheal intubation was studied in 20 patients without hypertension and 10 patients with hypertension to be operated on under general anesthesia. The patients were divided into three groups: the first group without hypertension (group C, n = 10) received saline as control, the second group without hypertension (group N, n = 10) received bolus injection of diltiazem, and the third group with hypertension (group H, n = 10) received bolus injection of diltiazem. Diltiazem was administered 2 min before intubation at a dose of 0.2 mg.kg-1 as a bolus injection. Changes of mean blood pressure, rate pressure product, pressure rate quotient in group H and N decreased significantly compared with group C. Changes of heart rate were comparable among the three groups. Complications were not remarkable except one case in which systolic pressure decreased to 80 mmHg. The results suggest that bolus injection of diltiazem at a dose of 0.2 mg.kg-1 attenuates cardiovascular response to laryngoscopy and tracheal intubation without serious complications.
在20例无高血压患者和10例需在全身麻醉下进行手术的高血压患者中,研究了地尔硫䓬对喉镜检查和气管插管时心血管反应的影响。患者被分为三组:第一组为无高血压患者(C组,n = 10),接受生理盐水作为对照;第二组为无高血压患者(N组,n = 10),接受地尔硫䓬静脉推注;第三组为高血压患者(H组,n = 10),接受地尔硫䓬静脉推注。在插管前2分钟,以0.2mg·kg-1的剂量静脉推注地尔硫䓬。与C组相比,H组和N组的平均血压、心率血压乘积、压力心率商的变化显著降低。三组间心率变化相当。除1例收缩压降至80mmHg外,并发症不明显。结果表明,以0.2mg·kg-1的剂量静脉推注地尔硫䓬可减轻喉镜检查和气管插管时的心血管反应,且无严重并发症。